mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.001 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.005 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.09 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |